RO4929097

DRUG2 trials

Sponsors

Hoffmann-La Roche, National Cancer Institute (NCI)

Conditions

Brain NeoplasmsLymphomaNon-Squamous Non-Small Cell Lung CancerOsteosarcomaSarcomaWilm's Tumor

Phase 1

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

WithdrawnNCT01236586

National Cancer Institute (NCI)Brain Neoplasms, Lymphoma, Osteosarcoma +2

Start: 2010-10-08End: 2011-04-13Updated: 2017-07-02

Phase 2

An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

CompletedNCT01070927

Hoffmann-La RocheNon-Squamous Non-Small Cell Lung Cancer

Start: 2010-01-31End: 2010-08-31Updated: 2016-11-02